[PHARMA] YoY Annualized Quarter Result on 30-Sep-2012 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
06-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 4.58%
YoY- 73.18%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 2,012,216 1,994,440 1,838,372 1,773,256 1,537,593 1,336,309 1,302,520 7.51%
PBT 118,673 116,968 79,986 132,088 75,757 64,217 71,930 8.69%
Tax -27,282 -40,162 -32,661 -37,856 -21,620 -21,201 -19,116 6.10%
NP 91,390 76,805 47,325 94,232 54,137 43,016 52,814 9.56%
-
NP to SH 90,642 76,196 45,849 92,860 53,620 43,520 51,038 10.04%
-
Tax Rate 22.99% 34.34% 40.83% 28.66% 28.54% 33.01% 26.58% -
Total Cost 1,920,825 1,917,634 1,791,046 1,679,024 1,483,456 1,293,293 1,249,705 7.42%
-
Net Worth 534,070 507,513 473,857 496,623 464,307 424,715 407,610 4.60%
Dividend
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Div 79,389 55,239 33,903 39,227 - 67,041 38,514 12.80%
Div Payout % 87.59% 72.50% 73.95% 42.24% - 154.05% 75.46% -
Equity
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Net Worth 534,070 507,513 473,857 496,623 464,307 424,715 407,610 4.60%
NOSH 258,880 258,935 258,938 117,683 106,983 106,981 106,984 15.86%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 4.54% 3.85% 2.57% 5.31% 3.52% 3.22% 4.05% -
ROE 16.97% 15.01% 9.68% 18.70% 11.55% 10.25% 12.52% -
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 777.28 770.25 709.97 1,506.80 1,437.23 1,249.11 1,217.49 -7.20%
EPS 35.01 29.43 17.71 78.91 50.12 40.68 47.71 -5.02%
DPS 30.67 21.33 13.09 33.33 0.00 62.67 36.00 -2.63%
NAPS 2.063 1.96 1.83 4.22 4.34 3.97 3.81 -9.71%
Adjusted Per Share Value based on latest NOSH - 117,646
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 139.62 138.38 127.55 123.04 106.68 92.72 90.37 7.51%
EPS 6.29 5.29 3.18 6.44 3.72 3.02 3.54 10.04%
DPS 5.51 3.83 2.35 2.72 0.00 4.65 2.67 12.82%
NAPS 0.3706 0.3521 0.3288 0.3446 0.3222 0.2947 0.2828 4.60%
Price Multiplier on Financial Quarter End Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 -
Price 6.50 4.63 4.82 7.55 5.90 4.98 4.09 -
P/RPS 0.84 0.60 0.68 0.50 0.41 0.40 0.34 16.26%
P/EPS 18.56 15.73 27.22 9.57 11.77 12.24 8.57 13.73%
EY 5.39 6.36 3.67 10.45 8.49 8.17 11.66 -12.06%
DY 4.72 4.61 2.72 4.42 0.00 12.58 8.80 -9.85%
P/NAPS 3.15 2.36 2.63 1.79 1.36 1.25 1.07 19.70%
Price Multiplier on Announcement Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 -
Price 6.50 4.45 4.72 8.25 5.90 4.92 3.93 -
P/RPS 0.84 0.58 0.66 0.55 0.41 0.39 0.32 17.44%
P/EPS 18.56 15.12 26.66 10.46 11.77 12.09 8.24 14.48%
EY 5.39 6.61 3.75 9.56 8.49 8.27 12.14 -12.65%
DY 4.72 4.79 2.77 4.04 0.00 12.74 9.16 -10.45%
P/NAPS 3.15 2.27 2.58 1.95 1.36 1.24 1.03 20.46%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment